Patheon to Host Webinar on “Accelerating the Drug Development Trajectory by Improving Solubility of New Compounds”

The company will host a complimentary webinar on Tuesday, June 11, 2013 at 2:15 p.m. British Summer Time (9:15 a.m. Eastern Standard Time).

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

(PRWEB) May 28, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, will host a complimentary webinar on “Accelerating the Drug Development Trajectory by Improving Solubility of New Compounds” on Tuesday, June 11, 2013 at 2:15 p.m. British Summer Time (9:15 a.m. Eastern Standard Time). The live webcast offers a roadmap to understanding and overcoming solubility issues in Phase I clinical trials. Discussions will focus on how companies can improve solubility to optimize drug development timelines and to achieve regulatory approval faster.

Participants will learn about streamlining first-in-man formulation development programs, with particular emphasis on the solubility/bioavailability enhancement of poorly soluble molecules. Patheon has developed SoluPath™, a fixed price, multiplatform solution to improve the bioavailability of poorly soluble molecules. During this webcast, Robin Platt, Ph.D., Operations Director for Patheon’s Milton Park, UK facility, and Jason Vaughn, Ph.D., Director of Formulation and Product Development for Patheon, will present data and case studies to showcase the advantages of using platforms, such as SoluPath™, to facilitate a faster route to the clinic.

To register for this event or to learn more visit the company’s website at http://www.patheon.com/Knowledge-Library/Events.aspx.

About Patheon
Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.